I bought the notes (back in May when you posted this) for more exposure on the chance the shares spike after they release guidance for full year net profit, or release their full year net profit which I expect to be $40 million+.
I don't see any downside risk, but I do see the potential of an upside spike when full year profit is released. Who knows how the market will value ~$40 million profit with the shares a PE ratio of 5. $2 isn't too far fetched IMO.
Not sure about buying the notes now though, there is only 2 payments remaining and currently trading for ~$1.74, so you'll be losing money assuming they repay the full value of $1.65 back in December (which they plan to do) without a spike in the share price above $1.65.
Can somebody help me out with the IMFG notes?
I've read somewhere that they most likely will need the money and won't be bought out in Dec - does anyone know how many payments are left on them and what they are paying?
Thanks!
Has anyone done an IV calc on this stock, I have rechecked my numbers a couple of times and for some reason I am getting an IV of around $5.50!! Clearly not right and I cant see where I have gone wrong, I have fiddled around with the convertible notes and dividend accounting but whatever I try makes the numbers bigger rather than smaller! Either its the bargain of the century - or I have made a fundamental error. (almost certain!)
Has anyone done an IV calc on this stock, I have rechecked my numbers a couple of times and for some reason I am getting an IV of around $5.50!! Clearly not right and I cant see where I have gone wrong, I have fiddled around with the convertible notes and dividend accounting but whatever I try makes the numbers bigger rather than smaller! Either its the bargain of the century - or I have made a fundamental error. (almost certain!)
How are you valuing it? When I bought it early last year I got a value around $2, with margin of safety. I mainly used the value of their existing portfolio and made some guesstimations as to how much cash would flow from them + the cash on the balance sheet. I didn't include anything from their US expansion because, well, it hasn't done anything yet.
I basically use the Montgomery formula and tables for calculating IV, I didnt include anything from the US stuff either, really based on current data rather than projected.
So what numbers did you plug in? Montgomery's formula is pretty flawed but I would imagine it's almost impossible with a lumpy earner like IMF to calculate IV based on his forumla.
IMF do provide quarterly case updates with expected case wins by year and by value, which makes it a pretty good candidate for a bit of DCF.
I plug in NPAT, Dividends, # of Shares and Equity for the 11/12 year, I have a RR of 12% by default. My workbook refers to Montgomery's tables for the calculation.
While I accept there are issues with his formula, that is true for any calculation of IV and at least it gives me a reference point for value. Its pretty hard to find stocks in the current market that give results using this method that indicate prices below value - so when one flags up with such a difference it piques my interest!
However no dividend was a bit disappointing - they have quite a bit of cash so not sure why they didn't part with some?
No franking credits available.
Thanks for that - is it noted in their report? I didn't see!
Was pretty heavily traded down today to finish at $1.50. Still on the sidelines and waiting...
Not disclosed (at least I didn't see it in there).
They don't generally have franking credits until the pay tax, which doesn't occur until FY year end. There is some commentary about in last year's report.
Also note, they generally like to have between $55-$70m in cash on their balance sheet.
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?